{"id":77754,"date":"2026-09-01T12:26:39","date_gmt":"2026-09-01T04:26:39","guid":{"rendered":"https:\/\/flcube.com\/?p=77754"},"modified":"2026-09-01T12:26:40","modified_gmt":"2026-09-01T04:26:40","slug":"trump-signs-nine-new-mfn-drug-pricing-agreements-expanding-pharma-deals-to-26-companies-covering-89-of-branded-market","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=77754","title":{"rendered":"Trump Signs Nine New MFN Drug Pricing Agreements, Expanding Pharma Deals to 26 Companies Covering 89% of Branded Market"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">President <strong>Donald Trump<\/strong> announced new agreements with nine pharmaceutical companies to lower <strong>prescription drug prices<\/strong> for Americans, aligning them with the lowest prices paid by other developed nations under the <strong>most-favored-nation (MFN)<\/strong> pricing framework. The additions bring the total number of pharmaceutical manufacturers with <strong>MFN deals<\/strong> to <strong>26<\/strong>, now covering <strong>89% of the branded drug market<\/strong> \u2014 and grant every state <strong>Medicaid<\/strong> program access to MFN pricing on products from the nine newly signed companies.<\/p>\n\n\n\n<h2 id=\"h-policy-milestone\" class=\"wp-block-heading\">Policy Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td>Announcement<\/td><td>New MFN pricing agreements with nine pharmaceutical companies<\/td><\/tr><tr><td>Announced By<\/td><td>President <strong>Donald Trump<\/strong><\/td><\/tr><tr><td>Date<\/td><td><strong>31 Aug 2026<\/strong><\/td><\/tr><tr><td>Cumulative MFN Deals<\/td><td><strong>26 pharmaceutical manufacturers<\/strong><\/td><\/tr><tr><td>Market Coverage<\/td><td><strong>89% of the branded drug market<\/strong><\/td><\/tr><tr><td>Key Beneficiary<\/td><td>Every state <strong>Medicaid<\/strong> program; projected billions of dollars in savings for Americans<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-participating-companies-the-nine-new-mfn-signatories\" class=\"wp-block-heading\">Participating Companies \u2014 The Nine New MFN Signatories<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Alcon<\/strong><\/li>\n\n\n\n<li><strong>Astellas<\/strong><\/li>\n\n\n\n<li><strong>BeOne<\/strong><\/li>\n\n\n\n<li><strong>BridgeBio<\/strong><\/li>\n\n\n\n<li><strong>CSL<\/strong><\/li>\n\n\n\n<li><strong>Kyowa Kirin<\/strong><\/li>\n\n\n\n<li><strong>Sun Pharma<\/strong><\/li>\n\n\n\n<li><strong>Teva Pharmaceuticals<\/strong><\/li>\n\n\n\n<li><strong>UCB<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Near-Universal Branded Coverage:<\/strong> With 26 manufacturers signed and 89% of the branded market covered, MFN pricing has moved from policy proposal to structural feature of the US prescription drug landscape<\/li>\n\n\n\n<li><strong>Medicaid Savings Engine:<\/strong> State Medicaid programs&#8217; access to MFN pricing across the nine new companies is expected to generate billions of dollars in savings, easing budget pressure on state healthcare systems<\/li>\n\n\n\n<li><strong>Pricing Reset for Specialty and Generics Players:<\/strong> The signatory list spans ophthalmology (<strong>Alcon<\/strong>), rare disease (<strong>BridgeBio<\/strong>), plasma-derived therapies (<strong>CSL<\/strong>), oncology generics (<strong>Sun Pharma<\/strong>, <strong>Teva<\/strong>), and neurology\/inflammation (<strong>UCB<\/strong>, <strong>Kyowa Kirin<\/strong>) \u2014 signaling breadth across both specialty and volume segments<\/li>\n\n\n\n<li><strong>Revenue Implications:<\/strong> Companies joining MFN frameworks trade lower US list prices for maintained market access \u2014 a calculation increasingly hard to refuse as participation approaches critical mass<\/li>\n\n\n\n<li><strong>Industry Precedent:<\/strong> With 89% coverage achieved, remaining holdouts face mounting pressure to negotiate, potentially completing near-total MFN alignment of the US branded market<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong> \u2014 This brief contains forward-looking statements regarding policy implementation, pricing effects, and projected savings that involve risks and uncertainties. Actual outcomes may differ materially. Nothing herein constitutes investment advice.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>President Donald Trump announced new agreements with nine pharmaceutical companies to lower prescription drug prices&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[4],"tags":[2906,353,2092,2545,4433,438,75,1880,1071,131],"class_list":["post-77754","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-alcon-laboratories","tag-astellas-pharma","tag-beone-medicines","tag-bridgebio-pharma","tag-csl-behring","tag-kyowa-kirin","tag-price-negotiations","tag-sun-pharmaceutical","tag-teva-pharmaceutical","tag-ucb"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Trump Signs Nine New MFN Drug Pricing Agreements, Expanding Pharma Deals to 26 Companies Covering 89% of Branded Market - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"President Donald Trump announced new agreements with nine pharmaceutical companies to lower prescription drug prices for Americans, aligning them with the lowest prices paid by other developed nations under the most-favored-nation (MFN) pricing framework. The additions bring the total number of pharmaceutical manufacturers with MFN deals to 26, now covering 89% of the branded drug market \u2014 and grant every state Medicaid program access to MFN pricing on products from the nine newly signed companies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=77754\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trump Signs Nine New MFN Drug Pricing Agreements, Expanding Pharma Deals to 26 Companies Covering 89% of Branded Market\" \/>\n<meta property=\"og:description\" content=\"President Donald Trump announced new agreements with nine pharmaceutical companies to lower prescription drug prices for Americans, aligning them with the lowest prices paid by other developed nations under the most-favored-nation (MFN) pricing framework. The additions bring the total number of pharmaceutical manufacturers with MFN deals to 26, now covering 89% of the branded drug market \u2014 and grant every state Medicaid program access to MFN pricing on products from the nine newly signed companies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=77754\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T04:26:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-01T04:26:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=77754#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=77754\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Trump Signs Nine New MFN Drug Pricing Agreements, Expanding Pharma Deals to 26 Companies Covering 89% of Branded Market\",\"datePublished\":\"2026-09-01T04:26:39+00:00\",\"dateModified\":\"2026-09-01T04:26:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=77754\"},\"wordCount\":338,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Alcon Laboratories\",\"Astellas Pharma\",\"BeOne Medicines\",\"BridgeBio Pharma\",\"CSL Behring\",\"Kyowa Kirin\",\"Price negotiations\",\"Sun Pharmaceutical\",\"Teva Pharmaceutical\",\"UCB\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=77754#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=77754\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=77754\",\"name\":\"Trump Signs Nine New MFN Drug Pricing Agreements, Expanding Pharma Deals to 26 Companies Covering 89% of Branded Market - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-09-01T04:26:39+00:00\",\"dateModified\":\"2026-09-01T04:26:40+00:00\",\"description\":\"President Donald Trump announced new agreements with nine pharmaceutical companies to lower prescription drug prices for Americans, aligning them with the lowest prices paid by other developed nations under the most-favored-nation (MFN) pricing framework. The additions bring the total number of pharmaceutical manufacturers with MFN deals to 26, now covering 89% of the branded drug market \u2014 and grant every state Medicaid program access to MFN pricing on products from the nine newly signed companies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=77754#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=77754\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=77754#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trump Signs Nine New MFN Drug Pricing Agreements, Expanding Pharma Deals to 26 Companies Covering 89% of Branded Market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Trump Signs Nine New MFN Drug Pricing Agreements, Expanding Pharma Deals to 26 Companies Covering 89% of Branded Market - Insight, China&#039;s Pharmaceutical Industry","description":"President Donald Trump announced new agreements with nine pharmaceutical companies to lower prescription drug prices for Americans, aligning them with the lowest prices paid by other developed nations under the most-favored-nation (MFN) pricing framework. The additions bring the total number of pharmaceutical manufacturers with MFN deals to 26, now covering 89% of the branded drug market \u2014 and grant every state Medicaid program access to MFN pricing on products from the nine newly signed companies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=77754","og_locale":"en_US","og_type":"article","og_title":"Trump Signs Nine New MFN Drug Pricing Agreements, Expanding Pharma Deals to 26 Companies Covering 89% of Branded Market","og_description":"President Donald Trump announced new agreements with nine pharmaceutical companies to lower prescription drug prices for Americans, aligning them with the lowest prices paid by other developed nations under the most-favored-nation (MFN) pricing framework. The additions bring the total number of pharmaceutical manufacturers with MFN deals to 26, now covering 89% of the branded drug market \u2014 and grant every state Medicaid program access to MFN pricing on products from the nine newly signed companies.","og_url":"https:\/\/flcube.com\/?p=77754","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-09-01T04:26:39+00:00","article_modified_time":"2026-09-01T04:26:40+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=77754#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=77754"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Trump Signs Nine New MFN Drug Pricing Agreements, Expanding Pharma Deals to 26 Companies Covering 89% of Branded Market","datePublished":"2026-09-01T04:26:39+00:00","dateModified":"2026-09-01T04:26:40+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=77754"},"wordCount":338,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Alcon Laboratories","Astellas Pharma","BeOne Medicines","BridgeBio Pharma","CSL Behring","Kyowa Kirin","Price negotiations","Sun Pharmaceutical","Teva Pharmaceutical","UCB"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=77754#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=77754","url":"https:\/\/flcube.com\/?p=77754","name":"Trump Signs Nine New MFN Drug Pricing Agreements, Expanding Pharma Deals to 26 Companies Covering 89% of Branded Market - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-09-01T04:26:39+00:00","dateModified":"2026-09-01T04:26:40+00:00","description":"President Donald Trump announced new agreements with nine pharmaceutical companies to lower prescription drug prices for Americans, aligning them with the lowest prices paid by other developed nations under the most-favored-nation (MFN) pricing framework. The additions bring the total number of pharmaceutical manufacturers with MFN deals to 26, now covering 89% of the branded drug market \u2014 and grant every state Medicaid program access to MFN pricing on products from the nine newly signed companies.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=77754#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=77754"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=77754#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Trump Signs Nine New MFN Drug Pricing Agreements, Expanding Pharma Deals to 26 Companies Covering 89% of Branded Market"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/77754","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=77754"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/77754\/revisions"}],"predecessor-version":[{"id":77755,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/77754\/revisions\/77755"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=77754"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=77754"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=77754"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}